{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:40:14Z","timestamp":1790080814269,"version":"4.0.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T00:00:00Z","timestamp":1592352000000},"content-version":"am","delay-in-days":382,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.amjmed.2018.12.032","type":"journal-article","created":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T01:05:59Z","timestamp":1547773559000},"page":"740-748.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Real-Life Benefits of Statins for Cardiovascular Prevention in Elderly Subjects: A Population-Based Cohort Study"],"prefix":"10.1016","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2568-1928","authenticated-orcid":false,"given":"Julien","family":"Bezin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohann","family":"Mansiaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe Gabriel","family":"Steg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Pariente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.amjmed.2018.12.032_bib0001","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1001\/jama.2016.15450","article-title":"Statin use for the primary prevention of cardiovascular disease in adults: US Preventive Services Task Force recommendation statement","volume":"316","author":"Bibbins-Domingo","year":"2016","journal-title":"JAMA"},{"issue":"39","key":"10.1016\/j.amjmed.2018.12.032_bib0002","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","article-title":"2016 ESC\/EAS Guidelines for the Management of Dyslipidaemias","volume":"37","author":"Catapano","year":"2016","journal-title":"Eur Heart J"},{"issue":"19","key":"10.1016\/j.amjmed.2018.12.032_bib0003","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1001\/jama.2016.15212","article-title":"Statins for primary prevention in older adults: uncertainty and the need for more evidence","volume":"316","author":"Gurwitz","year":"2016","journal-title":"JAMA"},{"issue":"10074","key":"10.1016\/j.amjmed.2018.12.032_bib0004","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S0140-6736(17)30721-3","article-title":"Lessons from the controversy over statins","volume":"389","author":"Godlee","year":"2017","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.amjmed.2018.12.032_bib0005","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1177\/2047487315588390","article-title":"Cardiovascular risk estimation in older persons: SCORE O.P","volume":"23","author":"Cooney","year":"2016","journal-title":"Eur J Prev Cardiol"},{"issue":"17","key":"10.1016\/j.amjmed.2018.12.032_bib0006","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jama.1994.03520170045034","article-title":"Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years","volume":"272","author":"Krumholz","year":"1994","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.amjmed.2018.12.032_bib0007","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/ageing\/afq129","article-title":"Lipid-lowering treatment to the end? A review of observational studies and RCTs on cholesterol and mortality in 80+-year olds","volume":"39","author":"Petersen","year":"2010","journal-title":"Age Ageing"},{"key":"10.1016\/j.amjmed.2018.12.032_bib0008","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2147\/CLEP.S104258","article-title":"Time trends in the prescription of statins for the primary prevention of cardiovascular disease in the United Kingdom: a cohort study using The Health Improvement Network primary care data","volume":"8","author":"O'Keeffe","year":"2016","journal-title":"Clin Epidemiol"},{"issue":"8","key":"10.1016\/j.amjmed.2018.12.032_bib0009","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/pds.4233","article-title":"The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology","volume":"26","author":"Bezin","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"10.1016\/j.amjmed.2018.12.032_bib0010","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/aje\/kwn135","article-title":"Immeasurable time bias in observational studies of drug effects on mortality","volume":"168","author":"Suissa","year":"2008","journal-title":"Am J Epidemiol"},{"issue":"6","key":"10.1016\/j.amjmed.2018.12.032_bib0011","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/fcp.12143","article-title":"Choice of ICD-10 codes for the identification of acute coronary syndrome in the French hospitalization database","volume":"29","author":"Bezin","year":"2015","journal-title":"Fundam Clin Pharmacol"},{"issue":"12","key":"10.1016\/j.amjmed.2018.12.032_bib0012","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1093\/aje\/kwr001","article-title":"Covariate selection in high-dimensional propensity score analyses of treatment effects in small samples","volume":"173","author":"Rassen","year":"2011","journal-title":"Am J Epidemiol"},{"issue":"4","key":"10.1016\/j.amjmed.2018.12.032_bib0013","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/EDE.0b013e3181a663cc","article-title":"High-dimensional propensity score adjustment in studies of treatment effects using health care claims data","volume":"20","author":"Schneeweiss","year":"2009","journal-title":"Epidemiology"},{"issue":"8","key":"10.1016\/j.amjmed.2018.12.032_bib0014","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/pds.2152","article-title":"Confounding adjustment via a semi-automated high-dimensional propensity score algorithm: an application to electronic medical records","volume":"20","author":"Toh","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"10.1016\/j.amjmed.2018.12.032_bib0015","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/s11606-010-1609-1","article-title":"Healthy user and related biases in observational studies of preventive interventions: a primer for physicians","volume":"26","author":"Shrank","year":"2011","journal-title":"J Gen Intern Med"},{"issue":"3","key":"10.1016\/j.amjmed.2018.12.032_bib0016","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/pds.4171","article-title":"Comparative effectiveness of recommended versus less intensive drug combinations in secondary prevention of acute coronary syndrome","volume":"26","author":"Bezin","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"10.1016\/j.amjmed.2018.12.032_bib0017","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2165\/00002512-199915060-00006","article-title":"Calcium antagonists in the post-myocardial infarction setting","volume":"15","author":"Bertolet","year":"1999","journal-title":"Drugs Aging"},{"issue":"2","key":"10.1016\/j.amjmed.2018.12.032_bib0018","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/jama.297.2.177","article-title":"Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction","volume":"297","author":"Rasmussen","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2018.12.032_bib0019","unstructured":"Rassen JA, Doherty M, Huang W, Schneeweiss S. Pharmacoepidemiology toolbox. Boston, MA. Available at: http:\/\/www.hdpharmacoepi.org. Accessed March 10, 2016."},{"issue":"9","key":"10.1016\/j.amjmed.2018.12.032_bib0020","doi-asserted-by":"crossref","first-page":"e72642","DOI":"10.1371\/journal.pone.0072642","article-title":"Long-term effects of statin treatment in elderly people: extended follow-up of the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)","volume":"8","author":"Lloyd","year":"2013","journal-title":"PLoS One"},{"issue":"9346","key":"10.1016\/j.amjmed.2018.12.032_bib0021","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0140-6736(02)11600-X","article-title":"Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial","volume":"360","author":"Shepherd","year":"2002","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.amjmed.2018.12.032_bib0022","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1161\/CIRCULATIONAHA.106.654756","article-title":"Effects of intensive versus moderate lipid-lowering therapy on myocardial ischemia in older patients with coronary heart disease: results of the Study Assessing Goals in the Elderly (SAGE)","volume":"115","author":"Deedwania","year":"2007","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.amjmed.2018.12.032_bib0023","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1016\/j.jacc.2013.07.069","article-title":"Benefits of statins in elderly subjects without established cardiovascular disease: a meta-analysis","volume":"62","author":"Savarese","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.amjmed.2018.12.032_bib0024","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1001\/jamainternmed.2017.1442","article-title":"Effect of statin treatment vs usual care on primary cardiovascular prevention among older adults: the ALLHAT-LLT randomized clinical trial","volume":"177","author":"Han","year":"2017","journal-title":"JAMA Intern Med"},{"issue":"9","key":"10.1016\/j.amjmed.2018.12.032_bib0025","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1111\/bcp.13291","article-title":"Outcomes in patients after myocardial infarction similar to those of the PEGASUS-TIMI 54 trial: A cohort study in the French national claims database","volume":"83","author":"Blin","year":"2017","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.amjmed.2018.12.032_bib0026","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.amjcard.2014.09.041","article-title":"Gender disparities in evidence-based statin therapy in patients with cardiovascular disease","volume":"115","author":"Virani","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjmed.2018.12.032_bib0027","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.phrs.2016.08.006","article-title":"Pharmacological treatments of cardiovascular diseases: evidence from real-life studies","volume":"118","author":"Salvo","year":"2017","journal-title":"Pharmacol Res"},{"issue":"9493","key":"10.1016\/j.amjmed.2018.12.032_bib0028","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.amjmed.2018.12.032_bib0029","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jacc.2006.04.070","article-title":"Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy","volume":"48","author":"Cannon","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"9976","key":"10.1016\/j.amjmed.2018.12.032_bib0030","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S0140-6736(14)61368-4","article-title":"Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials","volume":"385","author":"Fulcher","year":"2015","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.amjmed.2018.12.032_bib0031","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1001\/jamainternmed.2017.1457","article-title":"Risks of statin therapy in older adults","volume":"177","author":"Curfman","year":"2017","journal-title":"JAMA Intern Med"},{"issue":"10074","key":"10.1016\/j.amjmed.2018.12.032_bib0032","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0140-6736(17)30712-2","article-title":"Safety and efficacy of statins","volume":"389","author":"Bonnet","year":"2017","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.amjmed.2018.12.032_bib0033","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1001\/jamainternmed.2015.0289","article-title":"Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial","volume":"175","author":"Kutner","year":"2015","journal-title":"JAMA Intern Med"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934319300622?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934319300622?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:17:14Z","timestamp":1757582234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934319300622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0002934319300622"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2018.12.032","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-Life Benefits of Statins for Cardiovascular Prevention in Elderly Subjects: A Population-Based Cohort Study","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2018.12.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}